Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension

Journal of Hypertension

Volumn 14, Issue 2, 1996, Pages 223-228

  Agrawal, Bhuwnesh ^b   Berger, Alexandra ^b   Wolf, Klaus ^b   Luft, Friedrich C ^a  

^a FRANZ VOLHARD CLINIC   (Germany)

^b NONE

Author keywords

Cardiovascular risk; Hypertension; Left ventricular hypertrophy; Microalbuminuria; Myocardial infarction; Peripheral vascular disease; Stroke

Indexed keywords

CREATININE;

ADULT; ARTICLE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GERMANY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK; SCREENING; STROKE; TEST STRIP;

EID: 0029876704     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199602000-00011     Document Type: Article

References (33)

1. Viberti GC, Hill RD, Jarrett RJ: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, 1:1430-1432.
2. Neil A, Thorogood M, Hawkins M, Cohen D, Potok M, Mann J: A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993, 16:996-1003.
3. Mimran A, Ribstein J: Microalbuminuria in essential hypertension. Clin Exp Hypertens 1993, 15:1061-1067.
4. Ljungman S: Microalbuminuria in essential hypertension. Am J Hypertens 1990, 3 (12 Pt 1):956-60.
5. Rambausek M, Fliser D, Ritz E: Albuminuria of hypertensive patients. Clin Nephrol 1992, 38 (suppl 1):S40-545.
6. Ritz E, Fliser D: Clinical relevance of albuminuria in hypertensive patients. Clin Invest 1992, 70 (suppl 1):5114-5119.
7. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988, ii:531-534.
8. Marshall SM, Shearing PA, Alberti KGMM: Micral-Test strips evaluated for screening for albuminuria. Clin Chem 1992, 38:588-591.
9. Biampietro O, Penno G, Clerico A, Cruschelli L, Lucchetti A, Nannipieri M, et al.: Which method for quantifying 'microalbuminuria' in diabetics?: Comparison of several immunological methods for measurement of albumin in urine. Acta Diabetol 1992, 28:239-245.
10. Sau Cheung Tiu, Shui Shan Lee, Mei Wan Cheng: Comparison of six commercial techniques in the measurement of microalbuminuria in diabetic patients. Diabetes Care 1993, 16:616-620.
11. Ljungman S, Auurell M, Hartford M: Blood pressure and renal function. Acta Med Scand 1980, 208:17-25.
12. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Patterson JK: Microalbuminuria: potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990, 10:727-731.
13. Redon J, Gomez-Sanchez MA, Baldo E, Casal MC, Fernandez M, Miralles A, et al.: Micro-albuminuria is correlated with left ventricular hypertrophy in male hypertensive patients. J Hypertens 1991, 9 (suppl 6) :5148-5149.
14. Pedrinelli R, Di Bello V, Catapano G, Talarico L, Materazzi F, Santoro G, et al.: Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. Arterioscler Thromb 1993, 13:900-906.
15. Hickey NC, Shearman CP, Gosling P, Simms MH. Assessment of intermittent claudication by quantitation of exercise-induced microalbuminuria. Eur J Vasc Surg 1990, 4:603-606.
16. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttilae I, et al.: Microalbuminuria predicts the development of serum lipoprotein abnormalities favoring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990, 33:237-243.
17. Reverter JL, Santi M, Rubies-Prat J, Lucas A, Salinas I, Pizarro E, et al.: Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control. Diabetes Care 1994, 17:189-194.
18. Smellie WSA, Warwick GL: Primary hyperlipidemia is not associated with increased urinary albumin excretion. Nephrol Dial Transplant 1991, 6:398-401.
19. Volhard F, Fahr T: Die Bright'sche Nierenkrankheit. Klinik, Pathologie und Atlas, Berlin: Springer; 1914:225.
20. Kaplan NM: Microalbuminuria: a risk factor for vascular and renal complications of hypertension. Am J Med 1992, 92 (suppl 48) :8S-12S.
21. Cerasola G, Cottone S, D'lgnoto G: Microalbuminuria points out early renal and cardiovascular changes in essential hypertension. Rev Lat Cardiol 1992, 13:3-7.
22. Bigazzi R, Bianchi S, Campese V, Baldari G: Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992, 61:94-97.
23. Ljungman S, Wikstrand J, Hartford M, Aurell M, Lindstedt G, Berglund G: Effects of long-term antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension. Am J Hypertens 1993, 6:554-563.
24. Lindeman RD, Tobin JD, Shock NW: Association between blood pressure and the rate of decline in renal function with age. Kidney Int 1984, 26:861-868.
25. Ruilope LM, Alcazar JM, Hernandez E, Praga M, Lahera V, Rodicio JL: Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int 1994, 45 (suppl) :5171-5173.
26. Corradi L, Zoppi A, Tettamanti F, Malamani GD, Lazzari P, Fogari R: Smoking habits and microalbuminuria in hypertensive patients with type 2 diabetes mellitus. J Hypertens 1993, 11 :S190-S191.
27. Stehouwer CD, Nauta JJ, Yeldenrust GC, Hackeng WH, Donker AJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-inulin-dependent diabetes mellitus. Lancet 1992, 340:319-323.
28. Nichols TC, Bellinger DA, Tate DA: Von Willebrand factor and occlusive arterial thrombosis: a study In normal and Von Willebrand's disease pigs with diet induced hypercholesterolemia and atherosclerosis. Arterioscler Thromb 1990, 10:449-461.
29. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Oma G, Catapano G, et al.: Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994, 344:14-18.
30. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G: PAI 1 and factor VII activity are higher In IDDM patients with microalbuminuria. Diabetes 1994, 43:426-429.
31. Giaconi S, Levanti C, Fommei E, Innocenti F, Segheri G, Palla L, et al.: Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989, 2:259-261.
32. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM: Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994, 7:23-29.
33. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients: a marker for renal and cardiovascular risk factors. Hypertension 1994, 23:195-199.